Literature DB >> 24021315

Seroprevalence of rubella in the cord blood of pregnant women and congenital rubella incidence in Nha Trang, Vietnam.

Masami Miyakawa1, Hiroshi Yoshino2, Lay Myint Yoshida2, Emilia Vynnycky3, Hideki Motomura4, Le Huu Tho5, Vu Dinh Thiem6, Koya Ariyoshi2, Dang Duc Anh6, Hiroyuki Moriuchi7.   

Abstract

To investigate susceptibility to and factors associated with rubella infection among pregnant mothers and to estimate the burden of congenital rubella infection (CRI) in Vietnam where rubella-containing vaccine (RCV) is not included in the routine immunization program, we conducted a prospective cohort study in Nha Trang, Vietnam between 2009 and 2010. Rubella-specific immunoglobulin-M and immunoglobulin-G were investigated in cord blood samples by enzyme immunoassay. Corresponding clinical-epidemiological data were analyzed and the national congenital rubella syndrome (CRS) incidence was estimated using modeling. We enrolled 1988 pairs of mothers aged 17-45 years and their newborn babies. No mothers had received RCV. Multivariate analysis revealed that mothers aged 17-24 (aOR 2.5, 95% CI: 1.7-3.8) or 25-34 (1.4, 1.0-2.1) years were more likely to be susceptible than those aged 35-45 years. Overall 28.9% (574/1988, 95% CI: 26.9-30.9%) of mothers were seronegative. The CRI rate was 151 (95% CI: 0-322) per 100,000 live births. Modeling estimated that 3788 babies (95% CI: 3283-4143) were born with CRS annually in Vietnam with an overall CRS incidence of 234 (95% CI: 207-262) cases per 100,000 live births. A substantial proportion of women of childbearing age (WCBA) are at risk of rubella infection during pregnancy and this can result in a high frequency of miscarriage or burden of CRS across Vietnam. Prompt introduction of RCV into national immunization program with catch-up vaccination to children and WCBA will reduce CRI in Vietnam.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Congenital rubella syndrome; Cord blood; IgG; IgM; Incidence; Modeling; Seroprevalence; Women of childbearing age

Mesh:

Substances:

Year:  2013        PMID: 24021315     DOI: 10.1016/j.vaccine.2013.08.076

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

2.  Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012.

Authors:  B Mao; K Chheng; K Wannemuehler; E Vynnycky; S Buth; S C Soeung; S Reef; W Weldon; L Quick; C J Gregory
Journal:  Epidemiol Infect       Date:  2014-11-06       Impact factor: 4.434

3.  Population based cohort study for pediatric infectious diseases research in Vietnam.

Authors:  Lay-Myint Yoshida; Motoi Suzuki; Vu Dinh Thiem; Wolf Peter Smith; Ataru Tsuzuki; Vu Thi Thu Huong; Kensuke Takahashi; Masami Miyakawa; Nguyen Thi Hien Anh; Kiwao Watanabe; Nguyen Thu Thuy Ai; Le Huu Tho; Paul Kilgore; Hiroshi Yoshino; Michiko Toizumi; Michio Yasunami; Hiroyuki Moriuchi; Dang Duc Anh; Koya Ariyoshi
Journal:  Trop Med Health       Date:  2014-06

Review 4.  Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review.

Authors:  Emilia Vynnycky; Elisabeth J Adams; Felicity T Cutts; Susan E Reef; Ann Marie Navar; Emily Simons; Lay-Myint Yoshida; David W J Brown; Charlotte Jackson; Peter M Strebel; Alya J Dabbagh
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

Review 5.  Does Rubella Cause Autism: A 2015 Reappraisal?

Authors:  Jill Hutton
Journal:  Front Hum Neurosci       Date:  2016-02-01       Impact factor: 3.169

6.  Sensory defects and developmental delay among children with congenital rubella syndrome.

Authors:  Michiko Toizumi; Giang Thi Huong Nguyen; Hideki Motomura; Thanh Huu Nguyen; Enga Pham; Ken-Ichi Kaneko; Masafumi Uematsu; Hien Anh Thi Nguyen; Duc Anh Dang; Masahiro Hashizume; Lay-Myint Yoshida; Hiroyuki Moriuchi
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

7.  Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.

Authors:  Masahiko Hachiya; Shinsuke Miyano; Yoshio Mori; Emilia Vynnycky; Phath Keungsaneth; Phengta Vongphrachanh; Anonh Xeuatvongsa; Thongchanh Sisouk; Vilasak Som-Oulay; Bouaphan Khamphaphongphane; Bounthanom Sengkeopaseuth; Chansay Pathammavong; Kongxay Phounphenghak; Tomomi Kitamura; Makoto Takeda; Katsuhiro Komase
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

8.  Asthma, Rhinoconjunctivitis, Eczema, and the Association with Perinatal Anthropometric Factors in Vietnamese Children.

Authors:  Michiko Toizumi; Masahiro Hashizume; Hien Anh T Nguyen; Michio Yasunami; Noriko Kitamura; Chihiro Iwasaki; Mizuki Takegata; Hiroyuki Moriuchi; Duc Anh Dang; Koya Ariyoshi; Lay-Myint Yoshida
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

9.  Rubella Vaccination Coverage Among Women of Childbearing Age in Vietnam.

Authors:  Toan Thanh Thi Do; Anh Ngoc Nguyen; Xuan Thanh Thi Le; Ann Pongsakul; Quang Nhat Nguyen; Thanh Van Nguyen; Thang Huu Nguyen; Tri Minh Do; Huong Thi Le; Huong Lan Thi Nguyen; Nu Thi Truong; Chi Linh Hoang; Giang Thu Vu; Tung Thanh Tran; Tung Hoang Tran; Bach Xuan Tran; Carl A Latkin; Cyrus Sh Ho; Roger Cm Ho
Journal:  Int J Environ Res Public Health       Date:  2019-05-16       Impact factor: 3.390

10.  Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome.

Authors:  Michiko Toizumi; Cam Giang T Do; Hideki Motomura; Tin N Do; Hirofumi Fukunaga; Makiko Iijima; Nhan Nt Le; Hung Thanh Nguyen; Hiroyuki Moriuchi; Lay-Myint Yoshida
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.